Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new bibliographic citation for a Phase II trial of enfortumab vedotin in gastric and esophageal cancers was added, and the prior 'Online ahead of print' citation was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded a consolidated Locations section listing study sites across US states and international locations (e.g., Arizona, California, Ohio, Ontario, Aichi-ken, Tokyo, etc.). The former state- and country-specific location subsections were replaced.SummaryDifference2%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; no substantive content changes to the study details are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedAdded a PubMed auto-fill disclaimer indicating that publications are automatically filled from PubMed and may not pertain to the study. Updated the revision label to v3.3.1.SummaryDifference0.1%

- Check52 days agoChange DetectedThe funding-status notice banner was removed from the page. The study details and navigation remain unchanged.SummaryDifference0.2%

- Check59 days agoChange DetectedNew date labels such as 'Last Update Posted (Estimated)' and recent dates (e.g., 2025-11-03, 2025-10-31) were added to the Study Details page, reflecting update history and not altering study data or eligibility; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.